The Legalization of Cannabis Edibles Will Trigger the Next Wave of Marijuana IPOs

Get ready for Hexo Corp. (TSX:HEXO)(NYSE:HEXO) to soar when cannabis edibles are legalized.

| More on:

Marijuana stocks remain under considerable pressure, as a range of calamities and fears that the global legal marijuana market won’t be as large as originally claimed weigh on their value. These growing concerns have done little to curb the rash of impending initial public offerings (IPOs) for the legal cannabis industry, which is being touted as a superior alternative to pharmaceuticals, liquor, and tobacco.

Growing popularity of cannabis beverages

Canada’s legalization of cannabis edibles, extracts, and topicals on or before October 17, 2019, will be the next boon for Canadian pot stocks. The industry segment is estimated to worth somewhere between $2.5 billion and $2.7 billion annually and will have higher margins than cultivating dried flower. This creates a significant incentive for those companies involved in the manufacture of products containing cannabis extracts to IPO.

The Toronto Stock Exchange, especially the TSX Venture Exchange (TSXV), is becoming increasingly popular among companies seeking access to capital by going public. One cannabis company slated to IPO on the TSXV is brewer Province Brands.

It is leading the charge to formulate and market craft beer brewed from cannabis rather than infused with the drug. The brewer’s first beer was an alcoholic beverage brewed from hemp, and it is in the process of preparing a second that will be brewed from marijuana and made available once cannabis edibles are legalized. The company is constructing a 123,000 square foot brewery in Ontario and has already raised capital through a series of private offerings, with a series of patents pending for its marijuana brews.

A recent marijuana beverage IPO on the Canadian Stock Exchange (CSE) is BevCanna Enterprises (CSE:BEV). It is a manufacturer of cannabis-infused white-label drinks which debuted on the CSE on July 2, 2019; however, its stock has declined by 28% since then.

BevCanna owns a 100-acre outdoor cultivation site in British Columbia and has a 40,000 square foot Hazard Analysis Critical Control Points (HACCP) bottling and manufacturing facility. During its first phase of development, it intends to produce alkaline spring water bottled at the source, carbonated water, flavour-infused water, soluble powders, shots, and concentrates.

The growing consensus among industry pundits is that cannabis-brewed and -infused drinks in Canada will dominate the market, but that is all dependent on the legalization of edibles, marijuana-infused products, and extracts. According to Health Canada regulations, it will take 60 days from the date of legalization for it to process and approve the sale of cannabis-infused products.

That makes December 16, 2019, the earliest date that such drinks can hit the shelves and become available to consumers. There are also strict limitations on the tetrahydrocannabinol (THC) content, which is restricted to a maximum of 10 milligrams, and alcohol terminology cannot be used.

Established liquor and cannabis cultivators are also preparing to release cannabis beverage products. Molson Coors has created a joint enterprise with Hexo (TSX:HEXO)(NYSE:HEXO) focused on non-alcoholic cannabis-infused beverages through a standalone company in which it will have a controlling 57.5% interest. The cultivator has almost 1.8 million square feet of growing facilities that can produce 150,000 kilograms annually.

In March 2019, Hexo became the first marijuana company to join Food & Consumer Products of Canada, setting itself up to become a leading edibles and beverage producer. Its alliance with Molson Coors will allow it to leverage off that company’s experience in the production and sale of packaged alcoholic beverages and relationships in a heavily regulated industry.

Hexo, compared to many of its Canadian peers, is also an low-cost operator reporting a fiscal third-quarter 2019 cost of sales of $2.26 per gram. That underscores the considerable profitability of the joint venture with Molson Coors, where margins on cannabis beverages, like edibles, are expected to be significantly higher than on dried flower produced for recreational use.

Foolish takeaway

The legalization of edibles, extracts, infused, and topical cannabis products will cause the domestic market to expand rapidly, with some analysts expecting it to be worth anywhere up to $3 billion annually. That opportunity will trigger a raft of IPOs, as companies focused on manufacturing food and drink products seek to cash in on the growing popularity of marijuana products.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Matt Smith has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »